Which sensitizes the myocardium to catecholamines?
**Core Concept**
The question is testing the understanding of the mechanism by which certain factors increase the sensitivity of the myocardium to catecholamines, leading to increased contractility and potential arrhythmias. This concept is crucial in understanding the pathophysiology of various cardiac conditions.
**Why the Correct Answer is Right**
The correct answer is **Isoproterenol**, a non-selective beta-adrenergic agonist, which sensitizes the myocardium to catecholamines by increasing the expression and activity of beta-adrenergic receptors. This leads to an increase in the sensitivity of the heart to catecholamines, resulting in enhanced contractility and potential arrhythmias. The increased expression of beta-adrenergic receptors is mediated by the activation of protein kinase A (PKA), which phosphorylates and activates the beta-adrenergic receptor kinase (βARK), leading to an increase in the number of functional beta-adrenergic receptors on the surface of cardiac myocytes.
**Why Each Wrong Option is Incorrect**
* **Option A:** **Digoxin** is a cardiac glycoside that increases the contractility of the heart by inhibiting the Na+/K+-ATPase pump, but it does not sensitize the myocardium to catecholamines.
* **Option B:** **Calcium channel blockers**, such as verapamil, decrease the sensitivity of the myocardium to catecholamines by blocking the influx of calcium ions into cardiac myocytes.
* **Option C:** **Beta blockers**, such as propranolol, decrease the sensitivity of the myocardium to catecholamines by blocking beta-adrenergic receptors.
**Clinical Pearl / High-Yield Fact**
Isoproterenol can be used in the management of certain types of bradycardia, such as sinus bradycardia or heart block, but its use requires careful monitoring due to the risk of arrhythmias.
**Correct Answer: C. Isoproterenol**